Concepedia

David M. Rubitski

DM

8

Publications

624

Citations

8

H-Index

2009

Active since

Affiliations

Pfizer (United States)(Current)

David M. Rubitski is an author at Pfizer (United States) specializing in medicine, gene expression, and natural sciences.

Top concepts

Publications per year

2009–2023

8

Publications

8

Selective Inhibition of Casein Kinase 1ϵ Minimally Alters Circadian Clock Period

Kevin M. Walton, Katherine Fisher, David M. Rubitski et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 177 citations

Receptor-Mediated Delivery of CRISPR-Cas9 Endonuclease for Cell-Type-Specific Gene Editing

Romain Rouet, Benjamin A. Thuma, Marc D. Roy et al. · Journal of the American Chemical Society · 2018 · 152 citations · Full text

, , +17

Discovery of Two Clinical Histamine H <sub>3</sub> Receptor Antagonists: <i>trans</i> - <i>N</i> -Ethyl-3-fluoro-3-[3-fluoro-4-(pyrrolidinylmethyl)phenyl]cyclobutanecarboxamide (PF-03654746) and <i>trans</i> -3-Fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]- <i>N</i> -(2-methylpropyl)cyclobutanecarboxamide (PF-03654764)

Travis T. Wager, Betty Pettersen, Anne W. Schmidt et al. · Journal of Medicinal Chemistry · 2011 · 107 citations · Full text

The 5-Hydroxytryptamine4 Receptor Agonists Prucalopride and PRX-03140 Increase Acetylcholine and Histamine Levels in the Rat Prefrontal Cortex and the Power of Stimulated Hippocampal θ Oscillations

David E. Johnson, Elena M. Drummond, Sarah Grimwood et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 57 citations

Identification of Multiple 5-HT<sub>4</sub>Partial Agonist Clinical Candidates for the Treatment of Alzheimer’s Disease

Michael A. Brodney, David E. Johnson, Aarti Sawant‐Basak et al. · Journal of Medicinal Chemistry · 2012 · 42 citations · Full text

Rows per page

1–5 of 8